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Abstract 1 
Species of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex are 2 
important human pathogens which can be recovered from animals and food, potential 3 
sources for their dissemination. The aim of the present study was to characterise the 4 
Acinetobacter isolates recovered from market meat samples in Peru. From July 5 
through August 2012, 138 meat samples from six traditional markets in Lima were 6 
cultured in Lysogeny and Selenite broths followed by screening of Gram-negative 7 
bacteria in selective media. Bacterial isolates were identified by MALDI-TOF MS 8 
and DNA-based methods and assessed for their clonal relatedness and antimicrobial 9 
susceptibility. 10 
Twelve Acinetobacter isolates were recovered from calf samples. All but one strain 11 
were identified as members of the clinically-relevant Acinetobacter calcoaceticus-12 
Acinetobacter baumannii complex: 9 strains as Acinetobacter pittii, 1 strain as A. 13 
baumannii, and 1 strain as the recently described novel species A. dijkshoorniae.  14 
The remaining strain could not be identified at the species level unambiguously but all 15 
studies suggested close relatedness to A. bereziniae. All isolates were well susceptible 16 
to antibiotics. Based on macrorestriction analysis, six isolates were further selected 17 
and some of them were associated with novel MLST profiles. 18 
The presence of pathogenic Acinetobacter species in human consumption meat might 19 
pose a risk to public health as potential reservoirs for their further spread into the 20 
human population. Nevertheless, the Acinetobacter isolates from meat found in this 21 
study were not multidrug resistant and their prevalence was low. To our knowledge, 22 
this is also the first time that the A. dijkshoorniae species is reported in Peru. 23 




Abbreviations: ACB complex, Acinetobacter calcoaceticus–Acinetobacter 27 
baumannii complex; CC, clonal complex; MALDI-TOF MS, matrix-assisted laser 28 
desorption ionisation time-of-flight mass spectrometry; MIC, minimum inhibitory 29 
concentration; MLSA, multilocus sequence analysis; MLST, multilocus sequence 30 
typing; PFGE, pulse-field gel electrophoresis; ST, sequence type. 31 
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1. Introduction 32 
The genus Acinetobacter currently comprises 60 validly published species names 33 
including four pairs of synonyms and a number of tentative species without standing 34 
in nomenclature (https://apps.szu.cz/anemec/Classification.pdf, last accessed April 35 
2019), some of them environmental and some considered human pathogens. Among 36 
the latter, species within the Acinetobacter calcoaceticus-Acinetobacter baumannii 37 
(ACB) complex are of particular clinical relevance, often associated with nosocomial 38 
infections (Cosgaya et al., 2016; Nemec et al., 2015; Roca et al., 2012). Acinetobacter 39 
baumannii is clearly the most prevalent pathogen of the ACB complex, probably due 40 
to its inherent ability to persist and survive in the hospital environment as well as to 41 
acquire resistance to multiple antimicrobial drugs and disinfectants (Lee et al., 2017). 42 
Despite the clinical relevance of members of the ACB complex, pathogenic 43 
Acinetobacter spp. have also been reported from food and food-producing animals, 44 
which might constitute an overlooked reservoir and source of bacterial pathogens to 45 
the human population (Carvalheira et al., 2017a; Carvalheira et al., 2017b; Hamouda 46 
et al., 2011; Lupo et al., 2014). 47 
The aim of the present study was to analyse the phenotypic and genotypic 48 
characteristics of Acinetobacter spp. recovered from market meat samples in Peru as 49 
well as to characterise their clonal relatedness. 50 
 51 
2. Material and methods 52 
2.1. Samples and isolation method 53 
From July through August 2012, 138 meat samples from poultry (n=64), swine 54 
(n=30) and beef (n=44) were obtained by random sampling from six traditional 55 
markets scattered throughout the city of Lima, Peru. Meat samples were transported 56 
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in sterile bags to the laboratory, homogenised in a paddle blender (Stomacher 400 57 
circulator, Seward, UK) and 2 g of each were used to enrich the bacterial burden in 58 
overnight cultures with Lysogeny and Selenite broths. Liquid cultures were plated in 59 
different agar media such as Xylose Lysine Deoxycholate agar, Salmonella-Shigella 60 
agar, MacConkey agar and Hektoen agar (all from Oxoid, Basingstoke, UK) to select 61 
for different Enterobacteria (Ruiz-Roldan et al., 2018). Specific enrichment media or 62 
pre-enrichment steps for Acinetobacter were not used as this study was initially 63 
designed to capture Enterobacterales only. Further growth of bacterial isolates was 64 
performed in Columbia sheep blood agar plates (Becton Dickinson GmbH, 65 
Heidelberg, Germany) at 37ºC. 66 
2.2. Bacterial identification and typing 67 
2.2.1. Identification by matrix-assisted laser desorption/ionisation time-of-flight mass 68 
spectrometry (MALDI-TOF MS) 69 
Bacterial identification for all grown colonies was performed by MALDI-TOF MS in 70 
a Microflex LT benchtop instrument (Bruker Daltonics, Bremen, Germany). Spectra 71 
were analysed with the MALDI BioTyper software (version 3.1; Bruker Daltonics) 72 
using the pre-processing and BioTyper main spectrum (MSP) identification standard 73 
methods (mass range 2,000-20,000 m/z) against the default Bruker database 74 
(V.8.0.0.0). Accuracy of the identification was determined by a logarithmic score 75 
value resulting from the alignment of peaks to the best matching reference spectrum 76 
(Espinal et al., 2012). 77 
2.2.2. Selection of isolates for identification with molecular methods 78 
All isolates belonging to the Acinetobacter genus were analysed by Pulsed-field Gel 79 
Electrophoresis (PFGE) as described previously (Uwingabiye et al., 2017), using 80 
genomic digestions with the ApaI restriction enzyme. Electrophoresis was performed 81 
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in 1% InCertTM Agarose (Lonza, Rockland, ME, USA) and 0.5X TBE Buffer (pH 8.0) 82 
containing 0.02 g of thiourea using either a CHEF-DR III system (Bio-Rad 83 
Laboratories, Marnes-la-Coquette, France) or a CHEF-MapperTM apparatus (Bio-Rad 84 
Laboratories) at 6 V/cm2 with switch times ranging from 5 s to 35 s at an angle of 85 
120°, at temperature of 14 °C, for 20 h. 86 
Molecular patterns were analysed with the InfoQuestTM FP v.5.4 software (Bio-Rad 87 
Laboratories) and the unweighted pair group method with arithmetic mean to create 88 
dendrograms based on Dice’s similarity coefficient. Using bandwidth tolerance and 89 
optimisation values set at 1 and 1%, respectively, isolates were considered to belong 90 
to the same PFGE cluster (pulsotype) if their Dice similarity index was ≥85% 91 
(Durmaz et al., 2009). 92 
2.2.3. Identification to the species level and sequence typing 93 
For selected isolates, the partial sequences of the rpoB gene (zones 1 and 2) were 94 
amplified by PCR and sequenced using primers Ac696F and Ac1598R (902 bp), 95 
according to La Scola et al. (2006). Likewise, the partial sequences of cpn60, fusA, 96 
gltA, pyrG, recA, rplB, and rpoB, the seven housekeeping genes from the Pasteur 97 
multilocus sequence typing (MLST) scheme, were also amplified and sequenced 98 
according to Diancourt et al. (2010). Partial rpoB sequences and the concatenated 99 
partial sequences of MLST genes were used to analyse sequence similarity between 100 
the tested isolates and reference strains belonging to the ACB complex as well as 101 
other Acinetobacter species that were retrieved from public repositories (Cosgaya et 102 
al., 2016). Sequence alignment was done with Clustal Ω and phylogenetic trees were 103 
constructed using the neighbour-joining method, with genetic distances computed by 104 
Kimura’s two-parameter model (Kimura, 1980; Sievers et al., 2011). The allele 105 
sequences of housekeeping genes were submitted to the Acinetobacter MLST 106 
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database (http://pubmlst.org/abaumannii/) to identify the corresponding sequence 107 
types (STs). 108 
2.3. Antibiotic susceptibility testing 109 
Antibiotic susceptibility testing of all isolates of Acinetobacter was assessed by 110 
gradient diffusion (E test, AB bioMérieux, Solna, Sweden) on Mueller–Hinton agar 111 
plates (bioMérieux, Marcy-l'Étoile, France) in accordance with the European 112 
Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines for the 113 
following antimicrobials: amikacin, tobramycin, kanamycin, ciprofloxacin, 114 
levofloxacin, cefepime, ceftazidime, meropemen, imipenem, chloramphenicol and 115 
tigecycline. The minimum inhibitory concentrations (MICs) were interpreted 116 
according to EUCAST clinical breakpoints and expert rules for Acinetobacter 117 
(Version 8.0, January 2018), except for tigecycline, which was interpreted using the 118 
EUCAST breakpoints and rules for Enterobacteriaceae (Version 8.0, January 2018) 119 
((EUCAST), 2018). Susceptibility to colistin was assessed by broth microdilution as 120 
recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group 121 
(EUCAST, 2016). Escherichia coli ATCC 25922 and A. baumannii ATCC 19606 122 
were used as quality control strains. 123 
2.4 Nucleotide sequence accession numbers 124 
The partial rpoB sequences of Acinetobacter strains were submitted to GenBank with 125 
accession numbers MK382383 (APT-6), MK382384 (APT-1), MK382385 (APT-5), 126 
MK382386 (APT-7B), MK382387 (APT-8), MK382388 (APT-7T). 127 
 128 
3. Results and discussion 129 
3.1. Identification of Acinetobacter species and clonal relatedness of all isolates 130 
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Twelve isolates of the genus Acinetobacter were recovered on MacConkey agar plates 131 
from the meat samples of five different calves obtained in two independent markets in 132 
Lima, Peru. 133 
Species identification of the 12 isolates was initially performed by MALDI-TOF MS 134 
by comparing the spectra profiles against the updated Bruker taxonomy database 135 
(V.8.0.0.0) which included custom reference spectra for Acinetobacter dijkshoorniae 136 
and Acinetobacter seifertii, the novel members of the ACB complex (Marí-Almirall et 137 
al., 2017). 138 
Three isolates were identified as A. baumannii, Acinetobacter bereziniae and A. 139 
dijkshoorniae, respectively, and the remaining nine isolates were identified as 140 
Acinetobacter pittii. Of note, the log score values for the identification of five out of 141 
the nine A. pittii isolates ranged between 1.9 and 2.01, which constituted a poor 142 
probable species identification, according to the manufacturer’s specifications.  143 
The PFGE analysis of ApaI-digested genomic DNA revealed five distinct fingerprints 144 
(A-E) (Table 1). Acinetobacter pittii isolates recovered from meat samples from the 145 
same calf shared identical fingerprints (B and D), plus one A. pittii isolate that was 146 
isolated from meat derived from a third calf (together with A. bereziniae) and also 147 
presented the D fingerprint.  148 
Six isolates were selected for further characterisation, one representative isolate from 149 
each fingerprint plus the A. pittii isolate that derived from a different calf (Table 1). 150 
Identification at the species level for these isolates was re-evaluated using two 151 
different molecular methods; sequencing of the partial rpoB gene sequences (La Scola 152 
et al., 2006), and by multilocus sequence analysis (MLSA) of the concatenated partial 153 
sequences of all house-keeping genes used for MLST (Diancourt et al., 2010). 154 
Molecular methods confirmed the identification of A. baumannii, A. dijkshoorniae 155 
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and A. pittii isolates from fingerprints A-C. Isolates within fingerprint D comprised 156 
those isolates with low MALDI-TOF log score values for A. pittii and showed the 157 
highest sequence similarity to A. pittii (97.3-98.1% and 98.4-99.0% for rpoB and 158 
MLSA, respectively). This isolates were, therefore, considered as A. pittii, even 159 
though the A. pittii group often embraces strains that are somehow related to each 160 
other but do not always meet the technical requirements used for species 161 
circumscription. Finally, the isolate corresponding to fingerprint E, designated as A. 162 
bereziniae by MALDI-TOF MS, clustered together with Acinetobacter bereziniae 163 
isolates with 96.4-96.9% and 96.6-96.7% similarity for rpoB and MLSA, 164 
respectively. These values are slightly lower than similarities usually seen between 165 
strains of a single species (>97.5%; Nemec et al., 2015). Accordingly, this isolate was 166 
designated as A. bereziniae-like although whole-genome sequencing could aid to 167 
clarify the taxonomic position of this isolate. Nevertheless, we acknowledge that 168 
additional isolates with similar characteristics are needed before proposing the 169 
existence of new taxa. 170 
3.2. Susceptibility to antimicrobial agents and epidemiological typing 171 
Antimicrobial susceptibility testing of the selected isolates by gradient diffusion and 172 
broth microdilution (colistin) showed low MIC values to all the antimicrobial agents 173 
tested except for chloramphenicol, to which MIC values below 8 mg/L were only 174 
observed in both A. pittii isolates representative from fingerprint D (Table 1). Of note, 175 
all isolates showed baseline MIC values between 3 and 6 g/mL to ceftazidime and 176 
between 1 and 4 g/mL to cefepime, which might be attributed to the intrinsic 177 
resistance of Acinetobacter spp. to cephalosporins. These results are in agreement 178 
with those of Rafei et al. (2015), that showed susceptibility to most antimicrobials in 179 
Acinetobacter spp. recovered from soil, animals and food products, with only a few 180 
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carbapenem-resistant isolates that were associated to the carriage of acquired OXA-181 
type carbapenemases, and also with those from Hamouda et al. (2011) that reported 182 
high MIC values to chloramphenicol as well as similar baseline MIC values to 183 
ceftazidime. In contrast, Carvalheira et al. (2017a) showed higher prevalence of 184 
resistance to cephalosporins and quinolones in Acinetobacter spp. isolated from meat 185 
(43.5% and 42.9%, respectively), and surprisingly high prevalence of resistance to 186 
colistin and polymyxin B (41.7% and 35.1%, respectively), although MIC values 187 
were not provided and a wider variety of Acinetobacter species were reported. 188 
MLST studies identified the A. baumannii isolate as belonging to ST273, which had 189 
been previously reported in 2000 from a hospitalised patient in Spain and had also 190 
been identified from a calf in Switzerland in 2013 (Lupo et al., 2014). ST273 is 191 
clustered into clonal complex (CC) CC33, which contains STs related to clinical 192 
isolates. The A. pittii isolates from fingerprint D were assigned to ST312, an ST 193 
previously described from a patient in Belgium in 2009 but to our knowledge, never 194 
reported in animals and not included in any CC. The A. dijkshoorniae and A. 195 
bereziniae-like isolates and the A. pittii isolate from fingerprint B presented novel 196 
MLST alleles and were assigned new sequence types (ST1256, ST1258 and ST1257, 197 
respectively) by the curators at https://pubmlst.org/. None of them clustered in any 198 
CC either. 199 
3.3. Final remarks 200 
The identification of Acinetobacter isolates belonging to several species of the ACB 201 
group in raw meat samples is of particular concern, since these species are usually 202 
associated with the clinical setting. Previous studies had already reported the presence 203 
of species belonging to this group from diverse meat samples, including poultry, 204 
swine and beef, although members of the ACB group were not necessarily the most 205 
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prevalent species (Carvalheira et al., 2017a). In our study, Acinetobacter isolates were 206 
only recovered from beef samples and the majority of isolates were identified as A. 207 
pittii. Interestingly, the authors from a study in Lebanon (Rafei et al., 2015) also 208 
reported the presence of A. baumannii, A. pittii and A. bereziniae in cow meat 209 
samples, with a prevalence similar to that observed in our investigation (28% and 210 
27%, respectively) and A. pittii was again the predominant Acinetobacter species. 211 
Multidrug resistant Acinetobacter spp. from the ACB complex currently represent a 212 
serious threat to public health but, despite some of the Acinetobacter isolates 213 
recovered in the present study showing genetic links to clinical isolates, all isolates 214 
were susceptible to clinically relevant antibiotics and their overall prevalence was low 215 
(8.6%). Nevertheless, contaminated meat should not be neglected as a source for the 216 
transmission of Acinetobacter spp. into domestic and hospital settings where it may 217 
also contribute to the evolution of clinical lineages which, ultimately, might 218 
accumulate resistance genes. 219 
It is also worth mentioning that the actual burden of Acinetobacter spp. from market 220 
meat samples may be much higher than what was shown in our study, since specific 221 
enrichment media or pre-enrichment steps for Acinetobacter were not used. 222 
To our best knowledge, we also report here the first identification of the recently 223 
described A. dijkshoorniae in meat samples of animal origin as well as its first 224 
identification in Peru. 225 
 226 
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Table 1. Characteristics of the Acinetobacter spp. isolates recovered from market meat samples in Lima, Peru. 336 
Rows display the genotypic and phenotypic information of isolates under the same PFGE cluster and/or origin of the samples. Data was obtained 337 
from a representative isolate each. n, number of isolates; Calf, animal from which they were recovered; Area, the location of the markets in Lima; 338 
Isolate, designation of the representative isolate for each pulsotype; Species, identification to the species level; ST, sequence type; MIC, 339 
minimum inhibitory concentration; AMK, amikacin; TOB, tobramycin; KAN, kanamycin; CIP, ciprofloxacin; LVX, levofloxacin; COL, colistin; 340 
FEP, cefepime; CAZ, ceftazidime; MEM, meropenem; IPM, imipenem; CHL, chloramphenicol; TGC, tigecycline. 341 
 342 
       MIC (g/mL) 
PFGE n Calf Area Isolate Species ST AMK TOB KAN CIP LVX COL FEP CAZ MEM IPM CHL TGC 
A 1 I North APT-1 A. dijkshoorniae 1256 2 0.19 1.5 0.5 0.38 0.38 4 4 0.25 0.25 256 0.5 
B 4 II North APT-5 A. pittii 1257 3 0.19 1.5 0.25 0.38 0.38 4 6 0.38 0.38 96 0.38 
C 1 III Centre APT-6 A. baumannii 273 2 0.25 1 0.25 0.25 0.5 2 3 0.25 0.25 96 0.38 
D 1 IV Centre APT-7B A. pittii 312 1.5 0.125 1 0.25 0.25 0.125 3 3 0.19 0.25 4 0.38 
E 1 IV Centre APT-7T A. bereziniae-like 1258 0.75 0.047 0.047 0.25 0.25 1.5 1 4 0.38 0.25 16 0.38 
D 4 V Centre APT-8 A. pittii 312 1.5 0.125 1 0.38 0.25 0.125 3 3 0.25 0.25 8 0.19 
 343 
